Winthrop P. Rockefeller Cancer Institute


July 11, 2019

Subaru, Leukemia & Lymphoma Society Blanketing Myeloma Patients with Love

Linda Haymes

Myeloma patient John Tyler of Conway accepts a blanket from Shane Haas, communications manager of Subaru of Little Rock

July 12, 2019 | Patients undergoing treatment at the UAMS Myeloma Center received throw blankets recently along with written messages of hope, courtesy of the Subaru Loves to Care initiative. Six employees from the Subaru of Little Rock dealership — many of them with connections to cancer through their own loved ones — and the…


July 1, 2019

Cross-Country Cyclists Stop by UAMS Cancer Institute to Promote Research and Fundraising

Linda Haymes

Myeloma patient Melissa Durham of Strawberry, Arkansas, and her husband Eddie visited with nearly 30 students from The University of Texas at Austin in Texas who recently visted the UAMS Winthrop P. Rockefeller Cancer Institute. The students are part of a larger group cycling 4,000 miles from Austin to Anchorage, Alaska, in support of cancer treatment and research.

Nearly 30 students from The University of Texas at Austin in Texas, riding bikes from Austin to Anchorage, Alaska, were greeted by cheers recently when they stopped by the UAMS Winthrop P. Rockefeller Cancer Institute. The students, part of the 2019 Texas 4000 for Cancer, the longest annual charity bike ride in the world, began…


June 20, 2019

UAMS Researcher Awarded $1.75 Million Grant to Study New Therapies for Metastatic Melanoma

Susan Van Dusen

Alan Tackett, Ph.D., was awarded a National Cancer Institute grant of $1.75 million to support his ongoing research into new therapies for metatatic melanoma.

Alan Tackett, Ph.D., a cancer researcher at the University of Arkansas for Medical Sciences (UAMS), has received a five-year $1.75 million grant from the National Cancer Institute (NCI) to identify new tumor targets in the treatment of metastatic melanoma.


June 12, 2019

UAMS-Developed Cytophone Detects Melanoma in Earliest Stages, Could Prevent Fatal Disease Spread

Susan Van Dusen

Vladimir Zharov, Ph.D., Ds.C. (center) is pictured with collaborators (left to right) Laura Hutchins, M.D.; James Y. Suen, M.D.; Ekaterina I. Galanzha, M.D., Ph.D., D.Sc.; Eric Siegel, M.S.; Issam Makhoul, M.D.; Azemat Jamshidi-Parsian, M.S.; Mustafa Sarimollaoglu, Ph.D; and Aayire C. Yadem, M.S.

A University of Arkansas for Medical Sciences (UAMS) research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to detect and kill circulating tumor cells (CTCs) in the blood using a noninvasive device called Cytophone that integrates a laser, ultrasound and phone technologies.


June 10, 2019

Eight-Year Survivor of Two Deadly Cancers Thanks ‘Guardian Angel’

Amy Widner

Doctor next to patient, who is in hospital bed

The night before his cancer surgery in April 2011, Michael McGhee asked his church family to pray for him. “I laid my cigarettes on the altar and didn’t pick them up again,” McGhee said. Eight years later, McGhee is 72 and has survived not one, but two, cancers that are often deadly: esophageal cancer and…


June 4, 2019

Myeloma Patient in Remission, Grateful for Additional Time

Linda Haymes

Linda Reins of Tulsa, Oklahoma, and her husband Robert recently learned she is in complete remission. "Dr van Rhee has given me time and hope," she said.

Linda Reins, 73, of Tulsa, Oklahoma, is no stranger to cancer. In 1985, when she was 40, her local gynecologist’s office floored her with the first diagnosis. “They told me, ‘You’re pregnant and oh, you also have cervical cancer,’ said Reins, who had two teenaged sons at the time. “The next day, my husband at…


May 22, 2019

Commentary by UAMS’ van Rhee Featured in Blood Journal

Linda Haymes

“Significant progress has been made in recent years in the field of multicentric Castleman disease,” Frits van Rhee wrote in a recent commentary in Blood, a publication by the American Society of Hematology, noting several advancements.

Frits van Rhee, clinical director of the UAMS Myeloma Center, weighed in on a new combination therapy for treating newly diagnosed Castleman disease patients in the April 18 issue of Blood, a publication by the American Society of Hematology. In the commentary, “Storming the Castle with TCP,” van Rhee and coauthor Katie Stone, then-director of…


May 20, 2019

Thoracic Surgeon Steliga Honored by UAMS Cancer Institute Auxiliary

Susan Van Dusen

Matthew Steliga, M.D., (left) is joined by UAMS Cancer Institute Interim Director Laura Hutchins, M.D., following his introduction as the UAMS Cancer Institute Auxiliary Distinguished Honoree.

When Matthew Steliga, M.D., arrived at UAMS 10 years ago, he faced an uphill battle. Lung cancer rates in the state were skyrocketing, with an estimated 2,160 Arkansans losing their lives to the disease in 2009 alone. As UAMS’ only surgeon dedicated to the treatment of lung cancer, Steliga jumped in headfirst and began building…


May 15, 2019

UAMS Cancer Institute Bone Marrow Transplant Program Receives Internationally Recognized Accreditation

Susan Van Dusen

The Bone Marrow Transplant Program at the University of Arkansas for Medical Sciences (UAMS) has received an internationally recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT). 


May 8, 2019

Cancer Researchers Form Collaborations, Share Insight at Inaugural Retreat

Susan Van Dusen

UAMS cancer researchers gathered May 2 for the inaugural Winthrop P. Rockefeller Cancer Institute Research Retreat.

With about 125 cancer researchers and clinical scientists gathered in one spot, new ideas and collaborations are bound to develop.



Next page